{"id":6569,"date":"2016-03-28T10:35:35","date_gmt":"2016-03-28T14:35:35","guid":{"rendered":"http:\/\/geiselmed.dartmouth.edu\/news\/?p=6569"},"modified":"2016-03-30T10:37:18","modified_gmt":"2016-03-30T14:37:18","slug":"fda-needs-cure-for-conflict-heraldnet","status":"publish","type":"post","link":"https:\/\/geiselmed.dartmouth.edu\/news\/2016\/fda-needs-cure-for-conflict-heraldnet\/","title":{"rendered":"FDA Needs Cure for Conflict &#8211; <em>HeraldNet<\/em>"},"content":{"rendered":"<p><a href=\"http:\/\/www.heraldnet.com\/article\/20160328\/OPINION01\/160329268\" target=\"_blank\"><em>Read article<\/em><\/a> -\u00a0Lisa Schwartz, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, is quoted about how the FDA has set a disturbing precedent by approving an untested dose of the new insomnia drug Belsomra. \"For a deadly cancer with limited treatment this gamble might make sense, but not for a condition like insomnia and where Belsomra doesn't appear to work any better, or more safely, than available treatments,\" says Schwartz.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><a href=\"http:\/\/www.heraldnet.com\/article\/20160328\/OPINION01\/160329268\" target=\"_blank\"><em>Read article<\/em><\/a> &#8211;\u00a0Lisa Schwartz, professor of medicine, community and family medicine, and of The Dartmouth Institute for Health Policy and Clinical Practice, is quoted about how the FDA has set a disturbing precedent by approving an untested dose of the new insomnia drug Belsomra. &#8220;For a deadly cancer with limited treatment this gamble might make sense, but not for a condition like insomnia and where Belsomra doesn&#8217;t appear to work any better, or more safely, than available treatments,&#8221; says Schwartz.<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[5],"tags":[],"class_list":["post-6569","post","type-post","status-publish","format-standard","hentry","category-in-the-news","author-15"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p4r3h1-1HX","_links":{"self":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/6569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/comments?post=6569"}],"version-history":[{"count":1,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/6569\/revisions"}],"predecessor-version":[{"id":6570,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/posts\/6569\/revisions\/6570"}],"wp:attachment":[{"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/media?parent=6569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/categories?post=6569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/geiselmed.dartmouth.edu\/news\/wp-json\/wp\/v2\/tags?post=6569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}